Non-lipopeptide fungi-derived peptide antibiotics developed since 2000

Zhao, Pengchao; Xue, Yun ✉; Li, Jinghua; Li, Xin; Zu, Xiangyang; Zhao, Zhanqin ✉; Quan, Chunshan; Gao, Weina; Feng, Shuxiao

Angol nyelvű Tudományos Összefoglaló cikk (Folyóiratcikk)
Megjelent: BIOTECHNOLOGY LETTERS 0141-5492 1573-6776 41 (6-7) pp. 651-673 2019
  • SJR Scopus - Applied Microbiology and Biotechnology: Q2
Azonosítók
Szakterületek:
    The 2,5-diketopiperazines (DKPs) are the smallest cyclopeptides and their basic structure includes a six-membered piperazine nucleus. Typical peptides lack a special functional group in the oligopeptide nucleus. Both are produced by at least 35 representative genera of fungi, and possess huge potential as pharmaceutical drugs and biocontrol agents. To date, only cyclosporin A has been developed into a commercial product. This review summarises 186 fungi-derived compounds reported since 2000. Antibiotic (antibacterial, antifungal, synergistic antifungal, antiviral, antimycobacterial, antimalarial, antileishmanial, insecticidal, antitrypanosomal, nematicidal and antimicroalgal) activities are discussed for 107 of them, including 66 DKPs (14 epipolythiodioxopiperazines, 20 polysulphide bridge-free thiodiketopiperazines, and 32 sulphur-free prenylated indole DKPs), 15 highly N-methylated, and 26 non-highly N-methylated typical peptides. Structure-activity relationships, mechanisms of action, and research methods are covered in detail. Additionally, biosynthases of tardioxopiperazines and neoechinulins are highlighted. These compounds have attracted considerable interest within the pharmaceutical and agrochemical industries.
    Hivatkozás stílusok: IEEEACMAPAChicagoHarvardCSLMásolásNyomtatás
    2020-09-30 09:19